OPTIVANTAGE DH INJECTOR SYSTEM WITH ENHANCED COMMUNICATION

Injector, Contrast Medium, Automatic

MALLINCKRODT INC., LIEBEL-FLARSHEIM BUSINESS

The following data is part of a premarket notification filed by Mallinckrodt Inc., Liebel-flarsheim Business with the FDA for Optivantage Dh Injector System With Enhanced Communication.

Pre-market Notification Details

Device IDK063503
510k NumberK063503
Device Name:OPTIVANTAGE DH INJECTOR SYSTEM WITH ENHANCED COMMUNICATION
ClassificationInjector, Contrast Medium, Automatic
Applicant MALLINCKRODT INC., LIEBEL-FLARSHEIM BUSINESS 2111 EAST GALBRAITH RD. Cincinnati,  OH  45237
ContactDale Moore
CorrespondentDale Moore
MALLINCKRODT INC., LIEBEL-FLARSHEIM BUSINESS 2111 EAST GALBRAITH RD. Cincinnati,  OH  45237
Product CodeIZQ  
CFR Regulation Number870.1650 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2006-11-20
Decision Date2007-04-27
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
10746190004813 K063503 000
10746190002727 K063503 000
10746190004004 K063503 000
10746190004011 K063503 000
10746190004028 K063503 000
10746190004035 K063503 000
10746190004332 K063503 000
10746190004349 K063503 000
10746190004356 K063503 000
10746190004363 K063503 000
10746190004714 K063503 000
10746190004745 K063503 000
10746190004752 K063503 000
10746190004806 K063503 000
10746190002710 K063503 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.